Seek Returns

IQV vs. TMO: IQVIA vs. Thermo Fisher Scientific Stock Comparison

How do IQVIA (IQV) and Thermo Fisher Scientific (TMO) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

IQVIA (IQV) and Thermo Fisher Scientific (TMO) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Company profile comparison for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
Profile ItemIQVTMO
NameIQVIA Holdings Inc.Thermo Fisher Scientific Inc.
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization44.80 billion USD257.42 billion USD
CurrencyUSDUSD
ExchangeNYSENYSE
Listing DateMay 9, 2013March 17, 1980
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

IQV
TMO
GSPC
Loading price history…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for IQVIA (IQV) and Thermo Fisher Scientific (TMO). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for IQVIA (IQV) and Thermo Fisher Scientific (TMO). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
Total Return (1Y)32.11%24.62%
Total Return (3Y, Annualized)13.15%17.34%
Total Return (5Y, Annualized)2.00%3.11%

Risk Profile

Drawdown History

IQV
TMO
GSPC
Loading price history…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for IQVIA (IQV) and Thermo Fisher Scientific (TMO). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Risk profile metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
Volatility (1Y, Annualized)40.77%29.96%
Beta (5Y)1.140.83
Max Drawdown (5Y)-51.52%-40.95%
Avg. Volume (3M)1.40M2.10M

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
IQV and TMO are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
Sharpe Ratio (1Y)0.680.68
Sortino Ratio (1Y)1.031.02

Profitability

ROE (TTM)

Both IQVIA (IQV) at 21.39% and Thermo Fisher Scientific (TMO) at 13.38% sit in the top peer quartile for ROE, suggesting each generates more profit from shareholders’ equity than typical industry peers.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

21.39%

Max
109.18%
IQV
21.39%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.38%

Max
109.18%
TMO
13.38%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

For every dollar of sales, both IQVIA (IQV) at 8.05% and Thermo Fisher Scientific (TMO) at 14.94% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.05%

Max
18.05%
IQV
8.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

14.94%

Max
18.05%
TMO
14.94%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Thermo Fisher Scientific (TMO) at 20.19% operates in the top operating margin quartile, ahead of IQVIA (IQV) at 13.73%, which runs around its industry’s norm.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

13.73%

Max
83.12%
Q3
14.77%
IQV
13.73%
Median
0.00%
Q1
-78.82%
Min
-207.40%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

20.19%

Max
83.12%
TMO
20.19%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
ROE (TTM)21.39%13.38%
ROA (TTM)5.08%5.19%
Net Margin (TTM)8.05%14.94%
Operating Margin (TTM)13.73%20.19%
Gross Margin (TTM)33.07%41.26%

Growth

Revenue Growth

Both IQVIA (IQV) at 5.87% and Thermo Fisher Scientific (TMO) at 3.91% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their Revenue Growth across different time periods.

EPS Growth

Both IQVIA (IQV) at 4.67% and Thermo Fisher Scientific (TMO) at 7.32% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.

Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
Revenue Growth (YoY)5.87%3.91%
Revenue Growth (3Y CAGR)4.21%-0.27%
EPS Growth (YoY)4.67%7.32%
EPS Growth (3Y CAGR)11.08%0.21%

Financial Strength

Current Ratio (MRQ)

Both IQVIA (IQV) at 0.83 and Thermo Fisher Scientific (TMO) at 1.81 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.83

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
IQV
0.83
Min
0.10

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.81

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
TMO
1.81
Min
0.10
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their current ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Debt / Equity (MRQ)

Both balance sheets lean debt-heavy versus peers, but IQV is more stretched: Thermo Fisher Scientific (TMO) at 0.75 sits in the higher-leverage quartile and IQVIA (IQV) at 2.40 is above its industry benchmark range.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.40

IQV
2.40
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.75

Max
1.42
TMO
0.75
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
Current Ratio (MRQ)0.831.81
Debt / Equity (MRQ)2.400.75
Net Debt / EBITDA4.462.91

Dividends

Dividend Yield (TTM)

IQVIA (IQV) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a yield of 0.27%, ranking against industry peers normally.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.27%

TMO
0.27%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

IQVIA (IQV) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Thermo Fisher Scientific (TMO) reports a payout of 9.70%, ranking against industry peers normally.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

IQV
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.70%

TMO
9.70%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
Dividend Yield (TTM)0.00%0.27%
Dividend Payout Ratio (TTM)0.00%9.70%

Valuation

P/E Ratio (TTM)

Both IQVIA (IQV) at 33.07 and Thermo Fisher Scientific (TMO) at 36.64 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

33.07

Max
85.34
Q3
43.46
IQV
33.07
Median
26.69
Q1
13.30
Min
0.07

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

36.64

Max
85.34
Q3
43.46
TMO
36.64
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their P/E ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/S Ratio (TTM)

IQVIA (IQV) at 2.59 sits in the cheaper P/S ratio quartile while Thermo Fisher Scientific (TMO) at 5.44 prices around its industry’s middle — IQV costs less per dollar of sales, though read it alongside growth and margins.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.59

Max
58.18
Q3
25.77
Median
7.30
Q1
3.01
IQV
2.59
Min
0.01

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

5.44

Max
58.18
Q3
25.77
Median
7.30
TMO
5.44
Q1
3.01
Min
0.01
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Thermo Fisher Scientific (TMO) at 4.70 is valued about in line with its industry on P/B ratio, while IQVIA (IQV) at 6.73 carries an above-peer premium to book — IQV is pricier on assets.

IQV

Pharmaceuticals, Biotechnology & Life Sciences industry group

6.73

Max
13.53
IQV
6.73
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

TMO

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.70

Max
13.53
Q3
6.54
TMO
4.70
Median
3.25
Q1
1.69
Min
-5.59
Loading chart…
IQVIA (IQV) vs. Thermo Fisher Scientific (TMO): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for IQVIA (IQV) and Thermo Fisher Scientific (TMO)
MetricIQVTMO
P/E Ratio (TTM)33.0736.64
P/S Ratio (TTM)2.595.44
P/B Ratio (MRQ)6.734.70
Free Cash Flow Yield (TTM)4.72%2.50%